Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Wall Street Ends Higher as Crypto Stocks and Materials Rally 
Asian Stocks Slide as Samsung, Alibaba Lead Tech Selloff 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
US-Canada Tariff War Escalates With 50% Auto Duties 
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know 
Iran Allows Iraqi Oil Tankers Through Strait of Hormuz 
The pandemic is still disrupting young people’s careers 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears 
Oil Prices Edge Higher as US-Iran Sanctions Fuel Supply Concerns 
Can your cat recognise you by scent? New study shows it’s likely 
Norway Backs Barents Sea Oil and Gas Expansion 
China opens new Arctic trade route – but obstacles will prevent its wider use 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Add as a preferred source on Google
Hindustan Unilever (HUL) will invest in Zywie Ventures (OZiva) and Nutritionalab (Wellbeing Nutrition) to enter the health and well-being business category.
Unilever’s Indian subsidiary will initially acquire a 51 percent equity stake in OZiva, before purchasing the rest in three years.
A plant-based and clean-label consumer wellness brand, OZiva supplies lifestyle protein, hair and beauty supplements, and women’s health solutions.
OZiva’s current team will continue to operate all business functions.
Meanwhile, HUL is buying a 19.8 percent interest in Wellbeing Nutrition. The company’s product range includes marine collagen powder, Melts oral strips and health capsules. The current Wellbeing Nutrition team, led by founder and CEO Avnish Chhabria, will continue to operate the business.
According to Sanjiv Mehta, HUL’s CEO and managing director, the strategic investments give them an entry into the fast-growing health and wellbeing category.
Mehta added that HUL is well-positioned to support further scale-up of these businesses through our R&D, market development, distribution capabilities, and Unilever’s global health and wellbeing expertise.
Both transactions are set for completion within three months.
